<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1326</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2018-11-49-54</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Characterization of export prospect of domestic anti-influenza vaccines in Latin American countries and Carribeans</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Trukhin</surname><given-names>V. P.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Narkevich</surname><given-names>I. A.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nacharova</surname><given-names>E. P.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Uiba</surname><given-names>S. V.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Basakina</surname><given-names>I. I.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">St. Petersburg Research Institute of Vaccines and Serums and the Bacterial Preparation Factory</aff><aff id="aff-2">Saint-Petersburg State Chemical and Pharmaceutical University</aff><aff id="aff-3">Latin American institute for biotechnology Mechnikov</aff><pub-date date-type="epub" iso-8601-date="2018-12-11" publication-format="electronic"><day>11</day><month>12</month><year>2018</year></pub-date><issue>11</issue><fpage>49</fpage><lpage>54</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2018,</copyright-statement><copyright-year>2018</copyright-year></permissions><abstract>Requirement of Latin American countries in anti-influenza vaccines are analyzed. It is established, that market of Latin American countries and Carribeans сan regard as advanced product and technologic niche for domestic anti-influenza vaccines.</abstract><kwd-group xml:lang="en"><kwd>immunization</kwd><kwd>vaccine</kwd><kwd>influenza</kwd><kwd>export</kwd><kwd>high-tech transfer</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>иммунизация</kwd><kwd>вакцина</kwd><kwd>грипп</kwd><kwd>экспорт</kwd><kwd>трансфер высокоемких технологий</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Трухин В.П., Наркевич И.А., Начарова Е.П., Уйба С.В., Басакина И.И. Потенциал Российской Федерации в экспорте противогриппозных вакцин в страны латиноамериканского региона. Разработка и регистрация лекарственных средств. 2018; 2 (23): 156-162.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Лиознов Д.А., Горчакова О.В., Николаенко С.Л., Сабадаш Н.В., Трухин В.П., Начарова Е.П. и др. Сравнительная оценка эффективности и безопасности вакцин для профилактики гриппа у взрослых жителей мегаполиса. Медицинский алфавит. 2016; 1 (8): 27-30.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Palache A., Oriol-Mathieu V., Abelin A., Music T. Seasonal influenza vaccine dose distribution in 157 countries (2004-2011). Vaccine. 2014 Nov 12; 32 (48): 6369-6376.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>WHO, Miloud Kaddar, «Global Vaccine Market Features and Trends» Available from: http://who.int/influenza_vaccines_plan/resources/session_10_kaddar.pdf.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Programmes and projects URL. Available from: http://wwwwho.int/entity/en/.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Report of the second WHO consultation on the global action plan for influenza vaccines. (GAP), Geneva, Switzerland, 12-14 July 2011. Available from: http://www.who.int/ influenza_vaccines_plan/resources/gap2consul-tationreport.pdf.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Global action plan for the prevention and control of noncommunicable diseases 20132020. Available from: https://www.who.int/ nmh/events/ncd_action_plan/en/.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>World Population Prospects: The 2015 Revision, United Nations Available from: https://esa.un.org/unpd/wpp/publications/ files/key_findings_wpp_2015.pdf.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Concise Report on the World Population Situation in 2014, United Nations Available from:http://www.un.org/en/development/ desa/population/publications/pdf/trends/ Concise%20Report%20on%20the%20World%20 Population%20Situation%202014/en.pdf.</mixed-citation></ref></ref-list></back></article>
